|
FR2470599A1
(fr)
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US5026560A
(en)
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
|
US5000886A
(en)
|
1987-05-26 |
1991-03-19 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules and process of making the same
|
|
US5122519A
(en)
|
1989-06-27 |
1992-06-16 |
American Cyanamid Company |
Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
|
|
JPH0624959A
(ja)
|
1991-10-04 |
1994-02-01 |
Bayer Yakuhin Kk |
胃内浮遊型薬物徐放性固形製剤
|
|
US5538954A
(en)
|
1994-06-24 |
1996-07-23 |
A/S Dumex (Dumex Ltd.) |
Salts of tetracyclines
|
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
|
US6077533A
(en)
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
|
US6245350B1
(en)
|
1994-12-16 |
2001-06-12 |
Warner-Lambert Company |
Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
|
|
JP3670016B2
(ja)
|
1994-12-16 |
2005-07-13 |
ワーナー−ランバート・カンパニー |
カプレットをカプセル内に封入する方法及びかかる方法により得ることができる固体剤形
|
|
JPH0995440A
(ja)
|
1995-09-29 |
1997-04-08 |
Roussel Morishita Kk |
徐放性製剤およびその製造方法
|
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
CN1126537C
(zh)
|
1996-05-23 |
2003-11-05 |
株式会社三养社 |
可局部给药,可生物降解和持续释放的用于治疗牙周炎的药物组合物及其制备方法
|
|
US5789395A
(en)
|
1996-08-30 |
1998-08-04 |
The Research Foundation Of State University Of New York |
Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
|
|
US5780055A
(en)
|
1996-09-06 |
1998-07-14 |
University Of Maryland, Baltimore |
Cushioning beads and tablet comprising the same capable of forming a suspension
|
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US8828432B2
(en)
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
WO1998055107A1
(en)
|
1997-06-06 |
1998-12-10 |
Depomed, Inc. |
Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
|
|
DE69826660T2
(de)
|
1997-06-11 |
2005-10-06 |
The Procter & Gamble Company, Cincinnati |
Filmüberzogene tablette für verbesserte verträglichkeit im oberen magen-darmtrakt
|
|
US7201923B1
(en)
|
1998-03-23 |
2007-04-10 |
General Mills, Inc. |
Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
|
|
ES2331442T3
(es)
|
1998-03-23 |
2010-01-04 |
General Mills, Inc. |
Encapsulacion de componentes en productos comestibles.
|
|
ATE429813T1
(de)
|
1998-10-09 |
2009-05-15 |
Gen Mills Inc |
Verkapselung empfindlicher flüssiger komponenten in eine matrix zur gewinnung diskreter lagerbeständiger partikel
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
AU3192700A
(en)
|
1999-03-17 |
2000-10-04 |
Daiichi Pharmaceutical Co., Ltd. |
Medicinal compositions
|
|
US20030077301A1
(en)
|
1999-12-16 |
2003-04-24 |
Maibach Howard I. |
Topical pharmaceutical composition for the treatment of inflammatory dermatoses
|
|
CN1402629A
(zh)
|
1999-12-23 |
2003-03-12 |
辉瑞产品公司 |
提供提高的药物浓度的药物组合物
|
|
US6730320B2
(en)
|
2000-02-24 |
2004-05-04 |
Advancis Pharmaceutical Corp. |
Tetracycline antibiotic product, use and formulation thereof
|
|
US6638532B2
(en)
|
2000-02-24 |
2003-10-28 |
Advancis Pharmaceutical Corp. |
Tetracycline—doxycycline antibiotic composition
|
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
FR2811571B1
(fr)
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
|
JPWO2002024167A1
(ja)
*
|
2000-09-19 |
2004-01-29 |
第一製薬株式会社 |
医薬組成物
|
|
US6497901B1
(en)
|
2000-11-02 |
2002-12-24 |
Royer Biomedical, Inc. |
Resorbable matrices for delivery of bioactive compounds
|
|
UA80393C2
(uk)
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
|
|
IN192750B
(https=)
|
2000-12-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
|
AU2002256092C1
(en)
|
2001-04-05 |
2009-10-15 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
US7211267B2
(en)
|
2001-04-05 |
2007-05-01 |
Collagenex Pharmaceuticals, Inc. |
Methods of treating acne
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030104052A1
(en)
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
AU2002359768A1
(en)
|
2001-12-20 |
2003-10-27 |
Middlebrook Pharmaceuticals, Inc. |
Antibiotic product, use and formulation thereof
|
|
KR100540035B1
(ko)
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
|
JP2005526059A
(ja)
|
2002-03-07 |
2005-09-02 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質組成物
|
|
US6958161B2
(en)
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
|
AUPS167602A0
(en)
|
2002-04-12 |
2002-05-16 |
F.H. Faulding & Co. Limited |
An improved modified release preparation
|
|
US8192749B2
(en)
|
2003-04-16 |
2012-06-05 |
Galderma Laboratories Inc. |
Methods of simultaneously treating ocular rosacea and acne rosacea
|
|
EP1494681A4
(en)
|
2002-04-16 |
2008-08-06 |
Collagenex Pharm Inc |
PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
|
|
AU2003243607A1
(en)
|
2002-06-20 |
2004-01-06 |
Royer Biomedical, Inc. |
Resorbable matrices with coatings for delivery of bioactive compounds
|
|
KR101041767B1
(ko)
|
2002-06-25 |
2011-06-17 |
다케다 야쿠힌 고교 가부시키가이샤 |
서방성 조성물의 제조 방법
|
|
US8216609B2
(en)
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
EP1417958A1
(en)
|
2002-11-08 |
2004-05-12 |
Pari GmbH |
Wet granulation process
|
|
EP1589951B1
(en)
|
2003-01-03 |
2017-08-09 |
Supernus Pharmaceuticals, Inc. |
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
MXPA05010636A
(es)
|
2003-04-04 |
2005-12-12 |
Pharmacia Corp |
Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada.
|
|
ES2534827T3
(es)
|
2003-04-07 |
2015-04-29 |
Supernus Pharmaceuticals, Inc. |
Formulaciones de tetraciclinas en dosis única diaria
|
|
JP2006523703A
(ja)
|
2003-04-14 |
2006-10-19 |
シャイア ラボラトリーズ，インコーポレイテッド |
吸収ウィンドウ問題を克服するための、活性剤をバッカルまたは舌下の位置から放出する薬学的組成物
|
|
WO2004112713A2
(en)
|
2003-06-20 |
2004-12-29 |
Royer Biomedical, Inc. |
Drug polymer complexes
|
|
CN103040773A
(zh)
|
2003-07-25 |
2013-04-17 |
沃纳奇尔科特有限责任公司 |
多西环素金属络合物固体剂型
|
|
CA2535177A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
|
US20050049210A1
(en)
|
2003-08-27 |
2005-03-03 |
Idexx Laboratories, Inc. |
Methods for the controlled delivery of pharmacologically active compounds
|
|
CA2543940A1
(en)
|
2003-10-27 |
2005-05-19 |
Dow Corning Corporation |
Preparations for topical application and methods of delivering an active agent to a substrate
|
|
WO2005046651A1
(en)
|
2003-11-12 |
2005-05-26 |
Ranbaxy Laboratories Limited |
Liquid filled capsules of doxycycline
|
|
KR100844628B1
(ko)
|
2003-12-04 |
2008-07-07 |
화이자 프로덕츠 인크. |
제약상 다입자의 제조 방법
|
|
DE10358748A1
(de)
|
2003-12-12 |
2005-07-14 |
Lts Lohmann Therapie-Systeme Ag |
Darreichungsform basierend auf vernetzten hydrophilen Polymeren
|
|
US7410480B2
(en)
|
2004-04-21 |
2008-08-12 |
Acclarent, Inc. |
Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
|
|
DK1758557T3
(da)
|
2004-05-11 |
2011-10-24 |
Egalet Ltd |
Kvældbar doseringsform omfattende gellangummi
|
|
CA2578709C
(en)
|
2004-06-17 |
2010-06-15 |
Virun, Inc. |
Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents
|
|
US20080161273A1
(en)
|
2004-10-20 |
2008-07-03 |
Galderma Research & Development |
Method of Using Adapalene in Acne Maintenance Therapy
|
|
US8715724B2
(en)
|
2004-10-29 |
2014-05-06 |
Mayne Pharma International Pty Ltd |
Tabletting process
|
|
US20060147491A1
(en)
|
2005-01-05 |
2006-07-06 |
Dewitt David M |
Biodegradable coating compositions including multiple layers
|
|
US9205047B2
(en)
|
2005-04-25 |
2015-12-08 |
The Governing Council Of The University Of Toronto |
Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
|
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
|
US20100215744A1
(en)
|
2008-08-06 |
2010-08-26 |
Medicis Pharmaceutical Corporation |
Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical
|
|
US20080242642A1
(en)
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
|
US8920837B2
(en)
|
2005-07-01 |
2014-12-30 |
Rubicon Research Private Limited |
Sustained release dosage form
|
|
US20080200533A1
(en)
|
2005-07-04 |
2008-08-21 |
Ramu Krishnan |
Drug or Pharmaceutical Compounds and a Preparation Thereof
|
|
US9198862B2
(en)
|
2005-07-22 |
2015-12-01 |
Rubicon Research Private Limited |
Dispersible tablet composition
|
|
EP1942875B1
(en)
|
2005-08-24 |
2015-08-12 |
Rubicon Research Private Limited |
Controlled release formulation
|
|
FR2891459B1
(fr)
|
2005-09-30 |
2007-12-28 |
Flamel Technologies Sa |
Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
|
|
US20080318910A1
(en)
*
|
2005-10-04 |
2008-12-25 |
Mistral Pharma, Inc. |
Controlled-Release Oral Dosage Form
|
|
US8906392B2
(en)
|
2005-12-16 |
2014-12-09 |
University Of Kansas |
Nanocluster compositions and methods
|
|
EP2298324A1
(en)
|
2006-01-24 |
2011-03-23 |
Paratek Pharmaceuticals, Inc. |
Methods of increasing oral bioavailability of tetracyclines
|
|
JP5457830B2
(ja)
|
2006-04-03 |
2014-04-02 |
オディディ，イサ |
オルガノゾル被膜を含む制御放出送達デバイス
|
|
MX350380B
(es)
|
2006-05-09 |
2017-09-05 |
SpecGx LLC |
Formas de dosificacion solida de liberacion modificada en el orden de cero.
|
|
CA2655596C
(en)
|
2006-06-27 |
2011-10-25 |
Biovail Laboratories International Srl |
Multiparticulate osmotic delivery system
|
|
US20080014257A1
(en)
|
2006-07-14 |
2008-01-17 |
Par Pharmaceutical, Inc. |
Oral dosage forms
|
|
US20080268045A1
(en)
|
2006-11-09 |
2008-10-30 |
Proprius Pharmaceuticals, Inc. |
Sustained release methotrexate formulations and methods of use thereof
|
|
PT2120963T
(pt)
|
2006-12-21 |
2018-12-17 |
Paratek Pharm Innc |
Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele
|
|
GB0703627D0
(en)
|
2007-02-24 |
2007-04-04 |
Agt Sciences Ltd |
Aqueous formulations
|
|
US20100016322A1
(en)
|
2007-02-28 |
2010-01-21 |
Nagesh Nagaraju |
Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same
|
|
AU2008231033B2
(en)
|
2007-03-23 |
2012-08-30 |
Molecular Research Center, Inc. |
Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
|
|
EP2167037A1
(en)
|
2007-07-11 |
2010-03-31 |
Dow Corning Corporation |
Compositions for delivering a drug
|
|
CN101380474B
(zh)
|
2007-09-06 |
2012-07-25 |
北京大学 |
用于口服制剂的pH敏感性固体药物组合物及制备方法
|
|
US20090181068A1
(en)
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
|
EP2133071A1
(en)
|
2008-06-09 |
2009-12-16 |
Université de la Méditerranée |
Process for making gastroretentive dosage forms
|
|
EP2299953B1
(en)
|
2008-07-14 |
2017-04-12 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
|
WO2010017215A2
(en)
|
2008-08-04 |
2010-02-11 |
The Regents Of The University Of California |
Biodegradable microspheres and methods of use thereof
|
|
WO2010033800A2
(en)
|
2008-09-19 |
2010-03-25 |
Alacrity Biosciences, Inc. |
Tetracycline stabilizing formulations
|
|
EP2346351B1
(en)
|
2008-09-22 |
2019-07-03 |
Rubicon Research Private Limited |
Compositions exhibiting delayed transit through the gastrointestinal tract
|
|
DE102008048729A1
(de)
|
2008-09-24 |
2010-03-25 |
Add Technologies Ltd Advanced Drug Delivery |
Multipartikuläre Tabletten und Verfahren zur deren Herstellung
|
|
US20110268666A1
(en)
|
2008-09-29 |
2011-11-03 |
Yissum Research Development Company of the Research University of Jerusalem, Ltd. |
Novel gastroretentive delivery system
|
|
WO2010038234A1
(en)
|
2008-10-02 |
2010-04-08 |
Taro Pharmaceutical Industries Ltd. |
Combination product of spironolactone and doxycycline
|
|
KR20170048606A
(ko)
|
2008-10-02 |
2017-05-08 |
바이엘 컨수머 케어 악티엔게젤샤프트 |
증강된 항미생물 펩티드 및 단백질 수준과 관련된 피부 질환 또는 장애를 치료 또는 완화하기 위한 조성물
|
|
US9498431B2
(en)
|
2008-12-10 |
2016-11-22 |
Jianjian Xu |
Controlled releasing composition
|
|
CN102307576A
(zh)
|
2008-12-15 |
2012-01-04 |
班纳制药公司 |
用于增强水不溶性活性剂的释放和吸收的方法
|
|
WO2010120892A2
(en)
|
2009-04-14 |
2010-10-21 |
The Regents Of The University Of California |
Improved oral drug devices and drug formulations
|
|
GB0907019D0
(en)
|
2009-04-24 |
2009-06-03 |
Oxford Nutrascience Ltd |
Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
|
|
US20100291201A1
(en)
|
2009-05-14 |
2010-11-18 |
Cerovene, Inc. |
Coated pharmaceutical capsule dosage form
|
|
CA2766912A1
(en)
|
2009-05-28 |
2010-12-02 |
Northwestern University |
Nanodiamond particle complexes
|
|
WO2011044208A1
(en)
|
2009-10-06 |
2011-04-14 |
Scott Dorfner |
Antibiotic formulations providing reduced gastrointentestinal side effects
|
|
US9034830B2
(en)
|
2009-10-30 |
2015-05-19 |
Intratus, Inc. |
Methods and compositions for sustained delivery of drugs
|
|
US9327105B2
(en)
|
2010-03-26 |
2016-05-03 |
Itrace Biomedical Inc. |
Active transdermal drug delivery system and the method thereof
|
|
WO2011133217A1
(en)
|
2010-04-21 |
2011-10-27 |
Pharmacline, Llc |
Topical drug delivery system with dual carriers
|
|
WO2011156030A2
(en)
|
2010-06-11 |
2011-12-15 |
Precision Dermatology, Inc. |
High oil-content emollient aerosol foam compositions
|
|
CN103228268A
(zh)
|
2010-10-21 |
2013-07-31 |
高德美国际公司 |
缓释释放片剂及其制备方法
|
|
US8652516B1
(en)
|
2013-03-15 |
2014-02-18 |
Cerovene, Inc. |
Doxycycline formulations, and methods of treating rosacea
|